Boots dual action athlete's foot (+benzalkonium)

  • Home
  • Medicine
  • Boots dual action athlete's foot (+benzalkonium)

Boots dual action athlete's foot (+benzalkonium) Medicine

Overdose

Not applicable.

Contraindications

Hypersensitivity to any of the ingredients.

Incompatibilities

Not applicable.

List of excipients

Arlatone 983S

Cetostearyl alcohol

Dimethicone 20

Liquid paraffin

Glycerol

Purified water

Pharmaceutical form

Cream

Undesirable effects

Occasionally may cause skin irritation, hypersensitivity and contact dermatitis.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.

Therapeutic indications

Boots Dual Action Athlete's Foot Cream is indicated for the treatment and prevention of Athlete's Foot (Tinea Pedis). It is also effective in other conditions, such as Dhobie Itch (Tinea Cruris).

Pharmacodynamic properties

Tolnaftate is a well established drug substance having potent antifungal properties.

Benzalkonium chloride is a well established drug substance having potent anti-microbial properties.

Pharmacokinetic properties

Not applicable.

Date of revision of the text

4 June 2015

Name of the medicinal product

Boots Dual Action Athlete's Foot Cream

Marketing authorisation holder

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA

Special precautions for storage

Store in a cool place below 25°C.

Nature and contents of container

An internally lacquered metal tube with blind end nozzle. Tube to contain 25gm or 35gm.

Marketing authorisation number(s)

PL0014/0457

Qualitative and quantitative composition

Active ingredient

Quantity

Tolnaftate BP

1.0%w/w

Benzalkonium chloride solution BP

0.2%v/w

Special warnings and precautions for use

Keep all medicines out of the reach of children.

For external use only.

If symptoms persist consult your doctor.

Effects on ability to drive and use machines

No adverse effects known.

Dosage (Posology) and method of administration

Adults, children and the elderly: The affected area should be treated morning and night. Treatment should continue for at least a week after the infection has cleared.

Special precautions for disposal and other handling

None.

Date of first authorisation/renewal of the authorisation

12 April 1994